HCPCS J-code
J0791: crizanlizumab-tmca
Crizanlizumab 5 mg (sickle cell)
Code
J0791
Generic
crizanlizumab-tmca
Brands
Adakveo
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- FDA withdrawal — confirm current status
Frequently asked questions
What is HCPCS J0791?
Crizanlizumab 5 mg (sickle cell)
Why does insurance commonly deny J0791?
FDA withdrawal — confirm current status.
What brand-name drug uses J0791?
Adakveo.
Related
Appeal a J0791 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com